Moser, C., Lang, S. A., Mori, A., Hellerbrand, C., Schlitt, H. J., Geissler, E. K., . . . Stoeltzing, O. (2008). ENMD-1198, a novel tubulin-binding agent reduces HIF-1alpha and STAT3 activity in human hepatocellular carcinoma(HCC) cells, and inhibits growth and vascularization in vivo. BioMed Central.
استشهاد بنمط شيكاغوMoser, Christian, Sven A. Lang, Akira Mori, Claus Hellerbrand, Hans J. Schlitt, Edward K. Geissler, William E. Fogler, و Oliver Stoeltzing. ENMD-1198, a Novel Tubulin-binding Agent Reduces HIF-1alpha and STAT3 Activity in Human Hepatocellular Carcinoma(HCC) Cells, and Inhibits Growth and Vascularization in Vivo. BioMed Central, 2008.
MLA استشهادMoser, Christian, et al. ENMD-1198, a Novel Tubulin-binding Agent Reduces HIF-1alpha and STAT3 Activity in Human Hepatocellular Carcinoma(HCC) Cells, and Inhibits Growth and Vascularization in Vivo. BioMed Central, 2008.